JANUX THERAPEUTICS INC (JANX) Stock Analyst Earnings Estimates
NASDAQ:JANX - Nasdaq - US47103J1051 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.61M 136.54% | 8.083M -6.12% | 10.588M 30.99% | 453.329K -95.72% | 7.121M 1,470.82% | 7.418M 4.17% | 68.342M 821.30% | 330.19M 383.14% | 786.85M 138.30% | 1.089B 38.40% | 1.589B 45.91% | |
| EBITDA YoY % growth | -66.25M -101.86% | -71.024M -7.21% | -96.787M -36.27% | -149.012M -53.96% | -169.958M -14.06% | -284.182M -67.21% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -67.09M -103.74% | -72.979M -8.78% | -98.847M -35.45% | -161.886M -63.77% | -203.102M -25.46% | -265.191M -30.57% | -233.061M 12.12% | -55.693M 76.10% | 213.35M 483.08% | 430.18M 101.63% | 820.96M 90.84% | |
| Operating Margin | -779.21% | -902.87% | -933.58% | -35,710.53% | -2,852.15% | -3,574.96% | -341.02% | -16.87% | 27.11% | 39.50% | 51.67% | |
| EPS YoY % growth | -1.52 -19.43% | -1.34 11.84% | -1.28 4.48% | -2.09 -63.23% | -2.69 -28.80% | -3.55 -32.10% | -2.90 18.56% | -0.40 86.26% | 3.40 955.38% | 4.06 19.30% | 6.77 66.67% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.48 -336.66% | -0.54 -5.27% | -0.62 -71.98% | -0.77 -103.46% | -1.01 -109.49% | -1.04 -94.07% | -1.09 -75.29% |
| Revenue Q2Q % growth | 113.332K -98.73% | 170.003K -61.27% | 191.25K | 204K | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -36.424M -184.92% | -38.582M -12.50% | -40.28M -49.39% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.17M -154.45% | -38.252M -6.72% | -43.545M -50.04% | -63.309M -81.42% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.38 -26.67% | -0.40 | 0.02 | 5.55% |
| Q4 2024 Q2Q % growth | -0.36 -44.00% | -0.46 | 0.10 | 22.57% |
| Q3 2024 Q2Q % growth | -0.51 -104.00% | -0.33 | -0.18 | -52.65% |
| Q2 2024 Q2Q % growth | -0.11 73.81% | -0.32 | 0.21 | 65.71% |
| Q1 2024 Q2Q % growth | -0.30 28.57% | -0.34 | 0.04 | 11.21% |
| Q4 2023 Q2Q % growth | -0.25 35.90% | -0.40 | 0.15 | 37.59% |
| Q3 2023 Q2Q % growth | -0.25 37.50% | -0.48 | 0.23 | 47.85% |
| Q2 2023 Q2Q % growth | -0.42 -2.44% | -0.53 | 0.11 | 20.43% |
| Q1 2023 Q2Q % growth | -0.42 -31.25% | -0.50 | 0.08 | 16.27% |
| Q4 2022 Q2Q % growth | -0.39 -18.18% | -0.50 | 0.11 | 21.41% |
| Q3 2022 Q2Q % growth | -0.40 -53.85% | -0.50 | 0.10 | 19.47% |
| Q2 2022 Q2Q % growth | -0.41 33.87% | -0.38 | -0.03 | -8.25% |
| Q1 2022 Q2Q % growth | -0.32 | -0.38 | 0.06 | 14.75% |
| Q4 2021 Q2Q % growth | -0.33 | -0.31 | -0.02 | -5.27% |
| Q3 2021 Q2Q % growth | -0.26 | -0.18 | -0.08 | -44.28% |
| Q2 2021 Q2Q % growth | -0.62 | -0.13 | -0.49 | -367.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | 573.75K | -573.75K | -100.00% |
| Q4 2024 Q2Q % growth | -100.00% | 456.215K | -456.215K | -100.00% |
| Q3 2024 Q2Q % growth | 439K -82.56% | 1.674M | -1.235M | -73.78% |
| Q2 2024 Q2Q % growth | 8.897M 741.72% | 782.789K | 8.114M | 1,036.58% |
| Q1 2024 Q2Q % growth | 1.252M -38.87% | 778.648K | 473.352K | 60.79% |
| Q4 2023 Q2Q % growth | 2.461M -13.65% | 754.035K | 1.707M | 226.38% |
| Q3 2023 Q2Q % growth | 2.517M 39.06% | 862.41K | 1.655M | 191.86% |
| Q2 2023 Q2Q % growth | 1.057M -55.40% | 892.5K | 164.5K | 18.43% |
| Q1 2023 Q2Q % growth | 2.048M 28.81% | 685.695K | 1.362M | 198.68% |
| Q4 2022 Q2Q % growth | 2.85M 75.93% | 808.095K | 2.042M | 252.68% |
| Q3 2022 Q2Q % growth | 1.81M 56.03% | 758.197K | 1.052M | 138.72% |
| Q2 2022 Q2Q % growth | 2.37M 393.75% | 863.603K | 1.506M | 174.43% |
| Q1 2022 Q2Q % growth | 1.59M 318.42% | 834.697K | 755.303K | 90.49% |
| Q4 2021 Q2Q % growth | 1.62M | 441.997K | 1.178M | 266.52% |
| Q3 2021 Q2Q % growth | 1.16M | 135.997K | 1.024M | 752.96% |
| Q2 2021 Q2Q % growth | 480K | 204K | 276K | 135.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.69% | -7.84% | -2.32% | -5.24% |
| Revenue | -22.22% | -80.25% | 0% | -78.94% |